Enliven Therapeutics shares owned by Soleus Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Soleus Capital Management
from 13F filings
Historical chart of Soleus Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Soleus Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $16M | 1.0M | 15.40 |
| 2024-12-31 | $1.7M | 75k | 22.50 |
| 2024-09-30 | $6.1M | 240k | 25.54 |
| 2024-06-30 | $18M | 769k | 23.37 |